Search Results - Cameron Wellard
- Showing 1 - 12 results of 12
-
1
-
2
Real‐World Data on Lymphoma in Adolescents and Young Adults (AYA)—Report From the Lymphoma and Related Diseases Registry (LaRDR) by Evangeline Y. Wong, Cameron Wellard, Jun Yen Ng, Eliza Chung, Zoe K. McQuilten, Stephen Opat, Erica M. Wood, Dipti Talaulikar
Published in eJHaem (2025-02-01)Get full text
Article -
3
PB2698: MORE EFFICIENT DELIVERY OF HIGH-COST STANDARD-OF-CARE THERAPIES IN RELAPSED MULTIPLE MYELOMA USING REAL-TIME FEEDBACK OF PATIENT-REPORTED OUTCOME MEASURES: THE MY-PROMPT-2... by Elizabeth Moore, Simon Harrison, P. Joy Ho, Adam Irving, Tracy King, Georgia Mccaughan, Zoe Mcquilten, Peter Mollee, Susanna Park, Dennis Petrie, John Reynolds, Claudia Rutherford, Tina van Tonder, Cameron Wellard, Erica Wood, Andrew Spencer
Published in HemaSphere (2023-08-01)Get full text
Article -
4
Developing and validating a discrete-event simulation model of multiple myeloma disease outcomes and treatment pathways using a national clinical registry by Adam Irving, Dennis Petrie, Anthony Harris, Laura Fanning, Erica M. Wood, Elizabeth Moore, Cameron Wellard, Neil Waters, Kim Huynh, Bradley Augustson, Gordon Cook, Francesca Gay, Georgia McCaughan, Peter Mollee, Andrew Spencer, Zoe K. McQuilten
Published in PLoS ONE (2024-01-01)Get full text
Article -
5
Prognostic value of tumor bulk in modern management of common lymphoma subtypes: an Australasian Lymphoma and Related Diseases Registry study by Eliza Chung, Luke Wang, Cameron Wellard, Allison Barraclough, Belinda A. Campbell, Geoffrey Chong, Pietro Di Ciaccio, Gareth P. Gregory, Greg Hapgood, Anna M. Johnston, Constantine S. Tam, Stephen Opat, Erica M. Wood, Zoe K. McQuilten, Eliza A. Hawkes
Published in Haematologica (2025-09-01)Get full text
Article -
6
Definitions and use of tumor bulk in phase 3 lymphoma trials: a comprehensive literature review by Luke Wang, Eliza Chung, Cameron Wellard, Allison Barraclough, Belinda A. Campbell, Geoffrey Chong, Pietro R. Di Ciaccio, Gareth P. Gregory, Greg Hapgood, Anna M. Johnston, Constantine Tam, Stephen Opat, Erica M. Wood, Zoe K. McQuilten, Eliza A. Hawkes
Published in Blood Advances (2025-05-01)Get full text
Article -
7
The prognostic impact of t(11;14) in multiple myeloma: A real‐world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Reg... by Kenneth JC Lim, Cameron Wellard, Dipti Talaulikar, Joanne LC Tan, Joanna Loh, Pratheepan Puvanakumar, James A Kuzich, Michelle Ho, Matthew Murphy, Nicole Zeglinas, Michael SY Low, David Routledge, Andrew BM Lim, Simon D Gibbs, Hang Quach, Sue Morgan, Elizabeth Moore, Slavisa Ninkovic
Published in eJHaem (2023-08-01)Get full text
Article -
8
The cancer nursing workforce in Australia: a national survey exploring determinants of job satisfaction by Natalie Bradford, Elizabeth Moore, Karen Taylor, Olivia Cook, Lucy Gent, Theresa Beane, Natalie Williams, Kimberly Alexander, Erin Pitt, Jemma Still, Cameron Wellard, Gemma McErlean, Deborah Kirk, Leanne Monterosso, Alexandra McCarthy, Zerina Lokmic-Tomkins, Jessica Balson, Priscilla Gates, the CNSA Research Standing Committee, the CNSA Board of Directors
Published in BMC Nursing (2023-12-01)Get full text
Article -
9
P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REG... by Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoff Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A Hawkes
Published in HemaSphere (2023-08-01)Get full text
Article -
10
Poor outcomes for trial‐ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B‐cell lymphoma in routine care: An Australian Lymphoma and Related Diseases... by Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Y Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoffrey Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A. Hawkes
Published in eJHaem (2024-04-01)Get full text
Article -
11
The establishment of a multiple myeloma clinical registry in the Asia–Pacific region: The Asia–Pacific Myeloma and Related Diseases Registry (APAC MRDR) by Naomi Aoki, Pin-Yen Chen, Wenming Chen, Wee Joo Chng, Gin Gin Gan, Yeow Tee Goh, Jian Hou, Jeffrey Huang, Kihyun Kim, Je Jung Lee, Jin Lu, Zoe K. McQuilten, Chang Ki Min, Elizabeth Moore, Laura Oliver, Neil A. Waters, Cameron Wellard, Erica M. Wood, Su-Peng Yeh, Andrew Spencer, the APAC MRDR Investigators
Published in BMC Medical Research Methodology (2024-05-01)Get full text
Article -
12
Variation in immunoglobulin use and impact on survival in myeloma by Khai Li Chai, Cameron Wellard, LTP Thao, Naomi Aoki, Elizabeth M Moore, Bradley M Augustson, Akshay Bapat, Hilary Blacklock, Wee J Chng, Rachel Cooke, Cecily J Forsyth, Yeow‐Tee Goh, Nada Hamad, Simon J Harrison, P Joy Ho, Jay Hocking, Ian Kerridge, Jin Seok Kim, Kihyun Kim, Tracy King, Georgia J McCaughan, Peter Mollee, C Orla Morrissey, Nick Murphy, Hang Quach, Xuan Ni Tan, Allison CY Tso, Kimberly SQ Wong, Sung‐Soo Yoon, Andrew Spencer, Erica M Wood, Zoe K McQuilten
Published in eJHaem (2024-08-01)Get full text
Article
